CompanyDrug

US FDA Approves HutchMed and Takeda’s Fruzaqla for Metastatic Colorectal Cancer Treatment

CompanyDeals

Suzhou Porton Biologics Partners with BioMap to Enhance AAV Vector Design in Gene Therapy

CompanyDeals

CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&J, BeiGene, and Fosun Pharma Announce China Partnerships

CompanyDeals

Zymeworks and BeiGene Terminate Licensing Agreement for ZW49 ADC

CompanyDeals

Worg Pharmaceuticals Expands into Spain with Acquisition of Diater for EUR 150 Million

CompanyDrug

Janssen’s Nipocalimab Shows Promising Results in Phase II Rheumatoid Arthritis Trial

Company

Gilead Reports Q3 2023 Financials with 1% YOY Revenue Increase and Updates 2023 Outlook

CompanyDeals

AstraZeneca Expands China Presence with Over 30 Agreements at CIIE

Company

Moderna Initiates Construction of First China-Based Pharmaceutical Plant in Shanghai

CompanyDeals

Senti Biosciences and Celest Therapeutics Partner on CAR-NK Cell Therapy Clinical Trial in China

CompanyDeals

Eisai Partners with Shanghai Pharmaceuticals for Alzheimer’s Drug Leqembi in China

CompanyDeals

Bayer and Shanghai Pharmaceuticals Launch Co.Lab to Incubate Life Sciences Innovation in China